Touchlight boosts DNA manufacturing capacity with latest expansion
Pharmaceutical Technology
MAY 26, 2023
As per the company, dbDNA is suitable for rapid, scalable manufacture of GMP DNA and can incorporate gene sequences of sizes ranging from 500bp to 20kb, which are typically unstable as pDNA. Last year, Odimma Therapeutics began utilising Touchlight’s platform to develop an immunotherapy cancer treatment.
Let's personalize your content